NTRK1 and colonic neoplasm: For screening of tumors with a known low frequency of NTRK fusions where NGS is not routinely performed (e.g., colon cancer), Penault‐Llorca and colleagues recommend pan‐TRK immunohistochemistry (IHC) and, if positive, NGS.22